PF-Atlas › Клинические испытания › NCT06918288
Post-extubation Nasal Humidified High-flow Oxygen Versus Non-invasive Positive Pressure Ventilation
High flow nasal canula · Фаза 2
ID реестра
NCT06918288
Фаза
Фаза 2
Статус
Активно, набор закрыт
Препарат / вмешательство
High flow nasal canula
Спонсор
Benha University
Начало
2025-03-01
Набор участников
200
Центры
1
Об исследовании
Acute hypercapnic respiratory failure is characterized by elevated arterial carbon dioxide levels and commonly occurs in patients with chronic respiratory diseases. Patients with type II respiratory failure who experience difficult weaning from invasive mechanical ventilation are at increased risk of post-extubation respiratory failure and reintubation. This randomized clinical trial compared high-flow nasal cannula (HFNC) with non-invasive ventilation (NIV) as respiratory support immediately after extubation in patients aged over 50 years with type II respiratory failure and difficult weaning. The primary objective was to compare reintubation rates at 72 hours and 7 days after extubation.
Связанные материалы
Медицинская оговорка. Эта страница обобщает публичные данные исследования NCT06918288 только для информации. Это не медицинская рекомендация, не одобрение и не предложение участия. Проверяйте детали на ClinicalTrials.gov и у квалифицированного врача.